Cargando…
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
Psoriasis vulgaris is a chronic, immune-mediated systemic disease that affectŝ7.5 million people in the US. It can be treated with many therapies, often in combination, which include topicals, phototherapy, oral systemics, and biologics. Biologic agents target specific components of the immune syste...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774608/ https://www.ncbi.nlm.nih.gov/pubmed/29387609 http://dx.doi.org/10.2147/PTT.S129792 |